Screener
ADMA Biologics ADMA Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| Line item | Three Months ended June 30, 2026 | Three Months ended June 30, 2025 | Six Months ended June 30, 2026 | Six Months ended June 30, 2025 |
|---|---|---|---|---|
| Amortization of intangible assets | 55 | 32 | 110 | 57 |
| Gain on sale of plasma centers | - | - | (7,980) | - |
| Selling, general and administrative | 26,737 | 22,214 | 53,479 | 46,292 |
| Total operating expenses | 33,832 | 24,429 | 56,308 | 50,645 |
| INCOME FROM OPERATIONS | 52,445 | 42,798 | 110,719 | 77,678 |
| OTHER INCOME (EXPENSE): | ||||
| Interest and other income | 1,238 | 400 | 2,331 | 1,008 |
| Interest expense | (3,424) | (1,834) | (5,524) | (3,809) |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's total operating expenses?
- ADMA Biologics (ADMA) reported total operating expenses of $33.83M in Q2 2026.
- How has ADMA Biologics's total operating expenses changed year-over-year?
- ADMA Biologics's total operating expenses increased by 38.5% year-over-year, from $24.43M to $33.83M.
- What is the long-term trend for ADMA Biologics's total operating expenses?
- Over 4 years (2021 to 2025), ADMA Biologics's total operating expenses has grown at a 14.2% compound annual growth rate (CAGR), from $59.55M to $101.32M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about ADMA Biologics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude